Previous close | 89.51 |
Open | 89.56 |
Bid | 76.40 |
Ask | 79.95 |
Strike | 90.00 |
Expiry date | 2025-01-17 |
Day's range | 89.51 - 89.56 |
Contract range | N/A |
Volume | |
Open interest | 4 |
AbbVie (NYSE: ABBV) announced it is presenting 15 abstracts at the 2024 Digestive Disease Week (DDW) Annual Meeting, being held May 18-21 in Washington, D.C., and virtually.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.